Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder (2012)
- Authors:
- USP affiliated authors: FORLENZA, ORESTES VICENTE - FM ; GATTAZ, WAGNER FARID - FM
- Unidade: FM
- DOI: 10.1111/j.1600-0447.2012.01889.x
- Subjects: TRASNTORNO BIPOLAR; PROTEÍNAS QUINASES; DEPRESSÃO; MANIA
- Language: Inglês
- Imprenta:
- Publisher place: Copenhagen
- Date published: 2012
- Source:
- Título: Acta Psychiatrica Scandinavica
- ISSN: 0001-690X
- Volume/Número/Paginação/Ano: v. 126, n. 5, p. 332-341, 2012
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
SOEIRO-DE-SOUZA, M. G. et al. Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder. Acta Psychiatrica Scandinavica, v. 126, n. 5, p. 332-341, 2012Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1111/j.1600-0447.2012.01889.x/pdf. Acesso em: 23 jan. 2026. -
APA
Soeiro-de-Souza, M. G., Dias, V. V., Figueira, M. L., Forlenza, O. V., Gattaz, W. F., Zarate Jr., C. A., & Machado-Vieira, R. (2012). Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder. Acta Psychiatrica Scandinavica, 126( 5), 332-341. doi:10.1111/j.1600-0447.2012.01889.x -
NLM
Soeiro-de-Souza MG, Dias VV, Figueira ML, Forlenza OV, Gattaz WF, Zarate Jr. CA, Machado-Vieira R. Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder [Internet]. Acta Psychiatrica Scandinavica. 2012 ; 126( 5): 332-341.[citado 2026 jan. 23 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1600-0447.2012.01889.x/pdf -
Vancouver
Soeiro-de-Souza MG, Dias VV, Figueira ML, Forlenza OV, Gattaz WF, Zarate Jr. CA, Machado-Vieira R. Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder [Internet]. Acta Psychiatrica Scandinavica. 2012 ; 126( 5): 332-341.[citado 2026 jan. 23 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1600-0447.2012.01889.x/pdf - Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease
- Diagnosis and biomarkers of predementia in Alzheimer’s disease
- Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study
- Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein
- Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype
- Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression
- Inhibition of phospolipase A2 modulates glycogen synthase activity and tau phosphorylation in primary cultures of cortical and hippocampal neurons
- Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients
- Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study
- Reduced Cerebrospinal Fluid Levels of Brain-Derived Neurotrophic Factor Is Associated With Cognitive Impairment in Late-Life Major Depression
Informações sobre o DOI: 10.1111/j.1600-0447.2012.01889.x (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
